Sunday, September 13, 2026

New Hope for Solid Tumors? Korean Biotech Starts Phase 1 Trial of Targeted Drug

Digmbio secures 12 billion KRW for clinical trials of cancer drug DM5167 and advances treatment for degenerative brain diseases.

The “Next AI Phone” Takes Center Stage in San Francisco

Samsung unveils Galaxy S26 series with advanced AI, Exynos 2600 chip, and new privacy features, set for launch on February 25.

Hanwha Aerospace Hits Record High as Defense Stocks Soar Amid Trump’s Tough Talk on Russia

Hanwha Aerospace hits an all-time high, driven by bullish market trends following Trump's tough stance on Russia and NATO airspace violations.

Tag: AbbVie

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

Cancer Gone for 3 Years? This New Drug Is Making It Happen

AbbVie's Epkinly shows 96% long-term complete remission in R/R large B-cell lymphoma patients, highlighting its effectiveness as a therapy.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.